Showing results (201-210 of 255) with videos related to
Sort By:
Pageof 26
Alimentary Pharmacology & Therapeutics|February 24, 2010
Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimusK R Herrlinger, D N Barthel, K J Schmidt, et al.Alimentary Pharmacology & Therapeutics|November 6, 2012
Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patientsK J Schmidt, K R Herrlinger, J Emmrich, et al.Mucosal Immunology|April 11, 2013
Cell-mediated reduction of human β-defensin 1: a major role for mucosal thioredoxinS U Jaeger, B O Schroeder, U Meyer-Hoffert, et al.Journal of Clinical Pathology|April 30, 2003
Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori statusJ Wehkamp, K Schmidt, K R Herrlinger, et al.Archives of Dermatological Research|February 7, 1998
The promoter of the HaCaT keratinocyte differentiation-related gene keratin 4 contains a functional AP-2 binding siteR Wanner, J Zhang, T Dorbic, et al.Cancer Gene Therapy|August 5, 2000
Increased non-major histocompatibility complex-restricted lytic activity in melanoma patients vaccinated with cytokine gene-transfected autologous tumor cellsP Möller, H Möller, Y Sun, et al.Mucosal Immunology|October 30, 2014
Paneth cell α-defensin 6 (HD-6) is an antimicrobial peptideB O Schroeder, D Ehmann, J C Precht, et al.Haematologica|July 17, 2001
Quantification of human cells in NOD/SCID mice by duplex real-time polymerase-chain reactionA Nitsche, M Becker, I Junghahn, et al.Gastroenterology|September 30, 1998
Retinoic acid receptor gamma1 expression determines retinoid sensitivity in pancreatic carcinoma cellsA Kaiser, M Wolf-Breitinger, A Albers, et al.Gene Therapy|June 6, 1998
Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I studyY Sun, K Jurgovsky, P Möller, et al.Pageof 26